A detailed history of Hara Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hara Capital LLC holds 3,183 shares of ABBV stock, worth $563,231. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,183
Previous 3,296 3.43%
Holding current value
$563,231
Previous $565 Million 11.19%
% of portfolio
0.38%
Previous 0.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $18,513 - $22,524
-113 Reduced 3.43%
3,183 $629 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $24,772 - $28,225
-155 Reduced 4.49%
3,296 $600 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $474,857 - $534,801
3,451 New
3,451 $535 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hara Capital LLC Portfolio

Follow Hara Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hara Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hara Capital LLC with notifications on news.